SCHEMBL3286922

SCHEMBL3286922

O=c1c(Br)nn(CCCC(F)(F)F)c(=O)n1CCCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3286678 0.93 CTSK (0.35)
SCHEMBL3288166 0.91 TNF (0.38)
SCHEMBL3284453 0.91 TNF (0.38)
SCHEMBL3844316 0.88 LMNA (0.33)
SCHEMBL3286582 0.87 CTSK (0.37)
SCHEMBL3844466 0.86
SCHEMBL3288381 0.84 SCD (0.31)
SCHEMBL3291203 0.83 DPP4 (0.33)
SCHEMBL3290916 0.79 PDE4A (0.41)
SCHEMBL3285813 0.75 ADORA2B (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713971-B2 1,2,4-triazine derivatives, preparation and use thereof in human therapy PIERRE FABRE MEDICAMENT (FR) 2010-05-11 US disclosed
EP-1856065-B1 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY PF MEDICAMENT (FR) 2009-11-11 EP disclosed
US-20080167313-A1 1,2,4-Triazine Derivatives, Preparation and Use Thereof in Human Therapy PIERRE FABRE MEDICAMENT (FR) 2008-07-10 US disclosed